Product candidates for the treatment of excessive underarm sweating on one hand, and dry eye disease on the other, could help the two stocks highlighted in today’s article – a clinical-stage biotech company and a clinical-stage pharmaceutical company – surge by more than 100% (and potentially upwards of 500% in the case of one of the stocks), according to analysts at Oppenheimer. For more on these two stocks and their upside potential, CLICK HERE.